Where does IO Biotech ApS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), IO Biotech ApS ranks #19,930 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does IO Biotech ApS hold?

IO Biotech ApS holds 14 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is IO Biotech ApS's Innovation Score?

IO Biotech ApS has an Innovation Score of 46.0 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does IO Biotech ApS focus on?

IO Biotech ApS's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 14 patents, ranking #1,619 of 7,163 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is IO Biotech ApS's patent grant rate increasing or decreasing?

IO Biotech ApS's recent grant velocity is +250% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for IO Biotech ApS's patents?

IO Biotech ApS's patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the IO Biotech ApS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

IO Biotech ApS

USPTO PatentsView assignee record - 14 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, IO ranks #19,930 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 7 technology areas.

#19,930
of 49,997 US assignees by volume: Top 22%
by Innovation Score (46.0/100): 12.1
avg claims per patent: +250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19930 · Foreign Corporation #19,930 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,930/49,997
PHOTO-FINISH Intelligent…
CPC-NARROW A61K · 7 areas
INNOV-PAR 46.0/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +250% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Intelligent Material Solutions, Inc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How IO’s 46.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (20%) Velocity 20.0 pts (43%) Breadth 9.4 pts (20%) Claim depth 7.3 pts (16%)

Qualcomm Incorporated · highest

85
IO Biotech ApS · this assignee

46
3D Lighting… · lowest

7

What this shows IO's Innovation Score is 46.0/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for IO?

Each dot is one of IO’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). IO’s own 12.1 claims/patent is at or below the 14.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

IO vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where IO's grants concentrate

IO Biotech ApS is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2016. By volume, IO sits between Intelligent Material Solutions, Inc and Ipeg, Inc.

IO's three-year grant acceleration

IO Biotech ApS shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Intelligent Mater…

14
Interlink

14
Intermed Asia

14
Inventronics (Han…

14
Iodine Software

14
Ionaer Internatio…

14
Ipcomm

14
Ipeg

14
IO Biotech Aps ◀

14

What this shows IO holds 14 patents at rank #19,904, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near IO

By rank, the assignees closest to #19,904 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in IO's primary technology class.

IO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

IO Biotech ApS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	7.1%
2019	1	7.1%
2020	1	7.1%
2022	3	21.4%
2023	1	7.1%
2024	2	14.3%
2025partial year	5	35.7%

Which technologies does IO Biotech ApS patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

C12Y - Enzymes 10

C07K - Peptides 6

Y02A - Technologies FOR Adaptation TO Climate Change 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

IO Biotech ApS's patent record in context - here's where to go next.

IO Biotech ApS's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #19,930 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare IO Biotech ApS against Intelligent Material Solutions, Inc, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.